U.S. Fda Grants LYNPARZA® (olaparib) Orphan Drug Designation for Pancreatic Cancer
The United States Food and Drug Administration has granted the drug Lynparza® (olaparib) Orphan Drug Designation for the treatment of pancreatic cancer. Lynparza is used in the US to treat…